If you believe that every company news release serves the same function -- to goose the stock, then you will never be happy. I doubt KB is paying attention to stock price currently. He needs to raise enough capital to get to the revenue stream money, and he needs to write with his lawyers the best contract possible. I am sorry that message board posters neither understand what a CEO does nor care. Every news release put out until the deal is signed and sealed will be a selling opportunity. I suggest that the "non-believers" use those opportunities. It will make them happier. The worst thing anyone can tell a career long CEO who actually has skills in the area the company trades in, and a world of experience in product development, is that to a shareholder its all about share price and "F" the business. Does anyone have any idea how often KB hears this daily. People should be grateful KB has found multiple parties that were and are willing to buy the new product sight unseen.
IT IS NOW A “SHOW ME” COMPANY If you believe that
If you believe that every company news release serves the same function -- to goose the stock, then you will never be happy. I doubt KB is paying attention to stock price currently. He needs to raise enough capital to get to the revenue stream money, and he needs to write with his lawyers the best contract possible. I am sorry that message board posters neither understand what a CEO does nor care. Every news release put out until the deal is signed and sealed will be a selling opportunity. I suggest that the "non-believers" use those opportunities. It will make them happier. The worst thing anyone can tell a career long CEO who actually has skills in the area the company trades in, and a world of experience in product development, is that to a shareholder its all about share price and "F" the business. Does anyone have any idea how often KB hears this daily. People should be grateful KB has found multiple parties that were and are willing to buy the new product sight unseen.
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Elevate Your Gaming Experience with Betblast’s New Features
Unveiling the New Betblast Features for Gamers In a digital age where online gambling is immensely popular, players are consistently on the lookout for platforms that provide more than just entertainment but also real, significant rewards. One name that has emerged as a favorite among players for offering exceptional wins and rapid payouts is Betblast. As discussions...
Continue Reading
Kinetic Business Introduces Tailored Internet Solutions for SMBs
Kinetic Business Introduces an Innovative Internet Solution Kinetic Business is stepping into the spotlight with an exciting new product that caters specifically to the needs of small businesses. Their latest offering, known as Business Ready Internet, aims to revolutionize how small enterprises manage their connectivity, security, and overall operational efficiency....
Continue Reading
The Surge of Ship-to-Shore Cranes: Market Insights Ahead
Ship-to-Shore Cranes Market Overview As we look towards the future of the Ship-to-Shore (STS) cranes market, predictions indicate a significant expansion, with market size anticipated to reach USD 4.06 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 4.41% from 2025 to 2032. The increasing emphasis on technological advancements in port...
Continue Reading
Chicago Rivet & Machine Co. Announces Quarterly Dividend Update
Chicago Rivet & Machine Co. Announces Dividend Decision Chicago Rivet & Machine Co. (NYSE American: CVR) has made an important announcement regarding its dividend for shareholders. The Board of Directors has declared a quarterly cash dividend of $0.03 per share. This will be paid out to all shareholders who are recorded as of December 5 of the current fiscal year. While...
Continue Reading
Insights on the AstraZeneca PLC Class Action and Investor Rights
Understanding the AstraZeneca PLC Class Action A class action lawsuit has been initiated on behalf of stockholders who purchased shares of AstraZeneca PLC (NASDAQ: AZN) between specific dates. Robbins LLP is actively reminding these investors of the critical lead plaintiff deadline. This class action highlights important allegations surrounding AstraZeneca and offers...
Continue Reading